116 related articles for article (PubMed ID: 38014856)
1. Correction to "Establishment and characterization of a recurrent osteosarcoma cell line: OSA 1777".
J Orthop Res; 2024 Apr; 42(4):907. PubMed ID: 38014856
[No Abstract] [Full Text] [Related]
2. Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777.
Thanindratarn P; Li X; Dean DC; Nelson SD; Hornicek FJ; Duan Z
J Orthop Res; 2020 Apr; 38(4):902-910. PubMed ID: 31736134
[TBL] [Abstract][Full Text] [Related]
3. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
[TBL] [Abstract][Full Text] [Related]
4. Establishment and Characterization of a Human Small Cell Osteosarcoma Cancer Stem Cell Line: A New Possible In Vitro Model for Discovering Small Cell Osteosarcoma Biology.
Palmini G; Zonefrati R; Romagnoli C; Aldinucci A; Mavilia C; Leoncini G; Franchi A; Capanna R; Brandi ML
Stem Cells Int; 2016; 2016():3042198. PubMed ID: 27651797
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials.
Chen X; Yang TT; Wang W; Sun HH; Ma BA; Li CX; Ma Q; Yu Z; Fan QY
Cytotechnology; 2009 Nov; 61(1-2):37-44. PubMed ID: 20016965
[TBL] [Abstract][Full Text] [Related]
6. Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine.
Gola C; Giannuzzi D; Rinaldi A; Iussich S; Modesto P; Morello E; Buracco P; Aresu L; De Maria R
Front Vet Sci; 2021; 8():666838. PubMed ID: 34079834
[TBL] [Abstract][Full Text] [Related]
7. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
[TBL] [Abstract][Full Text] [Related]
8. Cellular and phenotypic characterization of canine osteosarcoma cell lines.
Legare ME; Bush J; Ashley AK; Kato T; Hanneman WH
J Cancer; 2011 May; 2():262-70. PubMed ID: 21552385
[TBL] [Abstract][Full Text] [Related]
9. A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients.
Wang JH; Zeng Z; Sun J; Chen Y; Gao X
Pharmacol Res; 2021 Nov; 173():105869. PubMed ID: 34481973
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy.
Inkol JM; Poon AC; Mutsaers AJ
Vet Comp Oncol; 2020 Dec; 18(4):559-569. PubMed ID: 32060984
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis.
Li H; He L; Tuo Y; Huang Y; Qian B
BMC Cancer; 2020 Oct; 20(1):1026. PubMed ID: 33097010
[TBL] [Abstract][Full Text] [Related]
12. Silencing hsa_circRNA_0008035 exerted repressive function on osteosarcoma cell growth and migration by upregulating microRNA-375.
Gong G; Han Z; Wang W; Xu Q; Zhang J
Cell Cycle; 2020 Sep; 19(17):2139-2147. PubMed ID: 32779548
[TBL] [Abstract][Full Text] [Related]
13. Osteocytes serve as a progenitor cell of osteosarcoma.
Sottnik JL; Campbell B; Mehra R; Behbahani-Nejad O; Hall CL; Keller ET
J Cell Biochem; 2014 Aug; 115(8):1420-9. PubMed ID: 24700678
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
[TBL] [Abstract][Full Text] [Related]
15. Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines.
Nam A; Song WJ; An JH; Rebhun RB; Youn HY; Seo KW
Vet Comp Oncol; 2022 Dec; 20(4):778-787. PubMed ID: 35521940
[TBL] [Abstract][Full Text] [Related]
16. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
[TBL] [Abstract][Full Text] [Related]
17. Investigating TrkA expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Sprandel IT; Fredrickson RL
J Vet Intern Med; 2008; 22(5):1181-8. PubMed ID: 18638015
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of canonical Hedgehog signaling pathway inhibition in canine osteosarcoma.
Baldanza VE; Rogic A; Yan W; Levine CB; Levine RA; Miller AD; McCleary-Wheeler AL
PLoS One; 2020; 15(4):e0231762. PubMed ID: 32348319
[TBL] [Abstract][Full Text] [Related]
19. BMI1 is expressed in canine osteosarcoma and contributes to cell growth and chemotherapy resistance.
Shahi MH; York D; Gandour-Edwards R; Withers SS; Holt R; Rebhun RB
PLoS One; 2015; 10(6):e0131006. PubMed ID: 26110620
[TBL] [Abstract][Full Text] [Related]
20. Investigating CXCR4 expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]